Wednesday October 18th 2017

Archive for November, 2014

Balance and Gait in People with Multiple Sclerosis: A Comparison with Healthy Controls and the Immediate Change after an Intervention based on the…

Balance and Gait in People with Multiple Sclerosis: A Comparison with Healthy Controls and the Immediate Change after an Intervention based on the…

This study provides further evidence of balance and gait limitations in people with MS and indicates that a single treatment based on principles of the Bobath concept to the foot and ankle can result in immediate improvements in balance and ankle PF during gait in people [Read More]

Distinct features of immunoglobulin G2 aquaporin‐4 antibody carriers with neuromyelitis optica

Distinct features of immunoglobulin G2 aquaporin‐4 antibody carriers with neuromyelitis optica

ConclusionsResults from the present study suggest that the characteristics of individuals with IgG2 AQP4 antibody as a main subclass are more similar to multiple sclerosis and somewhat distinct from NMO patients with IgG1 AQP4 antibody. (Source: Clinical and Experimental [Read More]

Management of multiple sclerosis and neuromyelitis optica in pregnancy and childbearing

Management of multiple sclerosis and neuromyelitis optica in pregnancy and childbearing

Abstract The age of onset of multiple sclerosis (MS) is between the 20s and 40s, and as this is the fertile age range for women, childbirth and pregnancy among MS patients are issues encountered by medical professionals on a daily basis. To ease the anxieties felt by [Read More]

 Page 1 of 156  1  2  3  4  5 » ...  Last » 

Latest Topics

Discovery may lead to new approach for treating MS

Discovery may lead to new approach for treating MS

Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous [Read More]

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Roche announced today that new data on OCREVUS ® (ocrelizumab) in people with relapsing and primary progressive forms [Read More]

All you need to know about dysesthesia

All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

Medical News Today: All you need to know about dysesthesia

Medical News Today: All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

MRI brain scans can reveal MS risk in children before clinical symptoms appear

MRI brain scans can reveal MS risk in children before clinical symptoms appear

By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and [Read More]